Spectral Med Inc (EDT) - Net Assets

Latest as of September 2025: CA$-68.66 Million CAD ≈ $-49.67 Million USD

Based on the latest financial reports, Spectral Med Inc (EDT) has net assets worth CA$-68.66 Million CAD (≈ $-49.67 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$8.12 Million ≈ $5.88 Million USD) and total liabilities (CA$76.79 Million ≈ $55.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Spectral Med Inc (EDT) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$-68.66 Million
% of Total Assets	-845.1%
Annual Growth Rate	N/A
5-Year Change	N/A
10-Year Change	-606.99%
Growth Volatility	260.05

Spectral Med Inc - Net Assets Trend (1992–2024)

This chart illustrates how Spectral Med Inc's net assets have evolved over time, based on quarterly financial data. Also explore total assets of Spectral Med Inc for the complete picture of this company's asset base.

Annual Net Assets for Spectral Med Inc (1992–2024)

The table below shows the annual net assets of Spectral Med Inc from 1992 to 2024. For live valuation and market cap data, see Spectral Med Inc stock valuation.

Year	Net Assets	Change
2024-12-31	CA$-27.55 Million ≈ $-19.93 Million	-66.45%
2023-12-31	CA$-16.55 Million ≈ $-11.97 Million	-547.96%
2022-12-31	CA$-2.55 Million ≈ $-1.85 Million	-162.55%
2021-12-31	CA$4.08 Million ≈ $2.95 Million	+710.31%
2020-12-31	CA$-669.00K ≈ $-483.94K	-129.60%
2019-12-31	CA$2.26 Million ≈ $1.63 Million	-64.52%
2018-12-31	CA$6.37 Million ≈ $4.61 Million	+122.88%
2017-12-31	CA$2.86 Million ≈ $2.07 Million	-50.91%
2016-12-31	CA$5.82 Million ≈ $4.21 Million	+7.16%
2015-12-31	CA$5.43 Million ≈ $3.93 Million	-38.40%
2014-12-31	CA$8.82 Million ≈ $6.38 Million	+54.85%
2013-12-31	CA$5.70 Million ≈ $4.12 Million	-46.13%
2012-12-31	CA$10.57 Million ≈ $7.65 Million	-44.17%
2011-12-31	CA$18.94 Million ≈ $13.70 Million	+20.27%
2010-12-31	CA$15.75 Million ≈ $11.39 Million	+1053.63%
2009-12-31	CA$1.36 Million ≈ $987.42K	-66.30%
2008-12-31	CA$4.05 Million ≈ $2.93 Million	-25.57%
2007-12-31	CA$5.44 Million ≈ $3.94 Million	-22.11%
2006-12-31	CA$6.99 Million ≈ $5.06 Million	+846.88%
2005-12-31	CA$738.00K ≈ $533.86K	-86.15%
2004-12-31	CA$5.33 Million ≈ $3.85 Million	-41.00%
2003-12-31	CA$9.03 Million ≈ $6.53 Million	+135.01%
2002-12-31	CA$3.84 Million ≈ $2.78 Million	-53.06%
2001-12-31	CA$8.19 Million ≈ $5.92 Million	+40.95%
2000-12-31	CA$5.81 Million ≈ $4.20 Million	-37.56%
1999-12-31	CA$9.30 Million ≈ $6.73 Million	-41.88%
1998-12-31	CA$16.00 Million ≈ $11.57 Million	-39.16%
1997-12-31	CA$26.30 Million ≈ $19.03 Million	-32.74%
1996-12-31	CA$39.10 Million ≈ $28.28 Million	+37.68%
1995-12-31	CA$28.40 Million ≈ $20.54 Million	-27.74%
1994-12-31	CA$39.30 Million ≈ $28.43 Million	+147.17%
1993-12-31	CA$15.90 Million ≈ $11.50 Million	+318.42%
1992-12-31	CA$3.80 Million ≈ $2.75 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Spectral Med Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 13723900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CA$90.57 Million	%
Other Comprehensive Income	CA$12.58 Million	%
Other Components	CA$10.15 Million	%
Total Equity	CA$-27.55 Million	100.00%

Spectral Med Inc Competitors by Market Cap

The table below lists competitors of Spectral Med Inc ranked by their market capitalization.

Company	Market Cap
MFS Intermediate Income Trust NYSE:MIN	$284.50 Million
James River Group Holdings Ltd NASDAQ:JRVR	$284.53 Million
Stellus Capital Investment NYSE:SCM	$284.55 Million
Global Standard Technology Limited KQ:083450	$284.56 Million
BROOGE ENERGY DL-0001 F:3SF	$284.43 Million
JINMAO PROPERTY SERVICES F:TZ0	$284.34 Million
Dredging Corporation of India Limited NSE:DREDGECORP	$284.17 Million
Yayla Agro Gida Sanayi ve Ticaret A.S. IS:YYLGD	$284.11 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Spectral Med Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -16,549,000 to -27,545,000, a change of -10,996,000.
Net loss of 15,402,000 reduced equity.
Share repurchases of 1,152,000 reduced equity.
Other comprehensive income decreased equity by 331,999.
Other factors increased equity by 5,889,999.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-15.40 Million	-55.92%
Share Repurchases	CA$1.15 Million	-4.18%
Other Comprehensive Income	CA$-332.00K	-1.21%
Other Changes	CA$5.89 Million	+21.38%
Total Change	CA$-	%

Book Value vs Market Value Analysis

This analysis compares Spectral Med Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1992-12-31	CA$0.94	CA$1.36	x
1993-12-31	CA$2.99	CA$1.36	x
1994-12-31	CA$5.85	CA$1.36	x
1995-12-31	CA$3.98	CA$1.36	x
1996-12-31	CA$4.74	CA$1.36	x
1997-12-31	CA$2.71	CA$1.36	x
1998-12-31	CA$1.63	CA$1.36	x
1999-12-31	CA$0.94	CA$1.36	x
2000-12-31	CA$0.54	CA$1.36	x
2001-12-31	CA$0.61	CA$1.36	x
2002-12-31	CA$0.27	CA$1.36	x
2003-12-31	CA$0.56	CA$1.36	x
2004-12-31	CA$0.29	CA$1.36	x
2005-12-31	CA$0.04	CA$1.36	x
2006-12-31	CA$0.26	CA$1.36	x
2007-12-31	CA$0.23	CA$1.36	x
2008-12-31	CA$0.17	CA$1.36	x
2009-12-31	CA$0.06	CA$1.36	x
2010-12-31	CA$0.24	CA$1.36	x
2011-12-31	CA$0.21	CA$1.36	x
2012-12-31	CA$0.09	CA$1.36	x
2013-12-31	CA$0.04	CA$1.36	x
2014-12-31	CA$0.06	CA$1.36	x
2015-12-31	CA$0.03	CA$1.36	x
2016-12-31	CA$0.03	CA$1.36	x
2017-12-31	CA$0.01	CA$1.36	x
2018-12-31	CA$0.03	CA$1.36	x
2019-12-31	CA$0.01	CA$1.36	x
2020-12-31	CA$0.00	CA$1.36	x
2021-12-31	CA$0.02	CA$1.36	x
2022-12-31	CA$-0.01	CA$1.36	x
2023-12-31	CA$-0.06	CA$1.36	x
2024-12-31	CA$-0.10	CA$1.36	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Spectral Med Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -673.75%
• Asset Turnover: 0.43x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-94.41%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1992	-84.21%	-3200.00%	0.02x	1.18x	CA$-3.58 Million
1993	-21.38%	-1700.00%	0.01x	1.06x	CA$-4.99 Million
1994	-22.90%	-1800.00%	0.01x	1.04x	CA$-12.93 Million
1995	-49.30%	-2333.33%	0.02x	1.08x	CA$-16.84 Million
1996	-34.78%	-906.67%	0.04x	1.09x	CA$-17.51 Million
1997	-49.05%	-238.89%	0.18x	1.15x	CA$-15.53 Million
1998	-64.38%	-98.10%	0.47x	1.39x	CA$-11.90 Million
1999	-81.72%	-77.55%	0.60x	1.74x	CA$-8.53 Million
2000	-92.44%	-48.92%	0.82x	2.32x	CA$-5.95 Million
2001	-65.60%	-40.55%	0.73x	2.21x	CA$-6.19 Million
2002	-115.38%	-30.60%	1.03x	3.65x	CA$-4.82 Million
2003	-23.88%	-18.35%	0.60x	2.18x	CA$-3.06 Million
2004	-138.13%	-73.57%	0.64x	2.92x	CA$-7.89 Million
2005	-630.76%	-64.01%	0.63x	15.66x	CA$-4.73 Million
2006	53.38%	171.97%	0.23x	1.34x	CA$3.03 Million
2007	-30.61%	-55.66%	0.38x	1.47x	CA$-2.21 Million
2008	-37.08%	-49.88%	0.42x	1.75x	CA$-1.91 Million
2009	-202.49%	-84.19%	0.65x	3.69x	CA$-2.90 Million
2010	-40.94%	-214.03%	0.18x	1.09x	CA$-8.09 Million
2011	-35.45%	-276.26%	0.12x	1.09x	CA$-8.61 Million
2012	-80.79%	-329.97%	0.21x	1.19x	CA$-9.60 Million
2013	-198.51%	-423.17%	0.28x	1.66x	CA$-11.88 Million
2014	-107.62%	-320.24%	0.25x	1.34x	CA$-10.37 Million
2015	-175.30%	-308.32%	0.37x	1.56x	CA$-10.07 Million
2016	-174.32%	-286.29%	0.50x	1.22x	CA$-10.73 Million
2017	-142.62%	-111.09%	1.06x	1.22x	CA$-4.36 Million
2018	-39.07%	-64.82%	0.55x	1.10x	CA$-3.13 Million
2019	-215.04%	-169.46%	0.72x	1.77x	CA$-5.09 Million
2020	0.00%	-433.03%	0.26x	0.00x	CA$-9.03 Million
2021	-215.16%	-440.13%	0.17x	2.83x	CA$-9.19 Million
2022	0.00%	-676.72%	0.14x	0.00x	CA$-11.03 Million
2023	0.00%	-980.10%	0.31x	0.00x	CA$-14.01 Million
2024	0.00%	-673.75%	0.43x	0.00x	CA$-12.65 Million

Industry Comparison

This section compares Spectral Med Inc's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

Industry: Diagnostics & Research
Average net assets among peers: $2,177,870
Average return on equity (ROE) among peers: -248.24%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Spectral Med Inc (EDT)	CA$-68.66 Million	-84.21%	N/A	$284.46 Million
Avricore Health Inc (AVCR)	$182.98K	-29.23%	0.57x	$5.13 Million
Leveljump Healthcare Corp (JUMP)	$6.20 Million	2.99%	0.98x	$4.19 Million
StageZero Life Sciences Ltd (SZLS)	$1.74 Million	-506.95%	0.72x	$3.58 Million
Telo Genomics Corp (TELO)	$590.06K	-459.79%	0.64x	$3.63 Million

About Spectral Med Inc

TO:EDT Canada Diagnostics & Research

Market Cap

$284.46 Million

CA$393.23 Million CAD

Market Cap Rank

#15183 Global

#458 in Canada

Share Price

CA$1.36

Change (1 day)

+0.74%

52-Week Range

CA$0.79 - CA$1.75

All Time High

CA$1.89